Literature DB >> 8093496

Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG)

H H Garcia1, R Gilman, M Martinez, V C Tsang, J B Pilcher, G Herrera, F Diaz, M Alvarado, E Miranda.   

Abstract

In countries where cysticercosis is endemic, the proportion of epilepsy due to cysticercosis is not well documented. To investigate the association between cysticercosis and epilepsy, we used the enzyme-linked immunoelectrotransfer blot (EITB) assay to detect serum antibodies to Taenia solium in 498 consecutive outpatients at a neurology clinic in Lima, Peru. Every patient was classified as epileptic (n = 189) or non-epileptic (n = 309) after neurological, and where possible electroencephalographic, examination. A substantially higher proportion of epileptic than non-epileptic patients was seropositive in the EITB (22 [12%] vs 8 [3%], p < 0.001). 19% of epileptic patients born outside Lima, 20% of those with late-onset epilepsy, and 29% of patients with both these characteristics were seropositive. Thus, in Peru, cysticercosis is an important aetiological factor for epilepsy.

Entities:  

Mesh:

Year:  1993        PMID: 8093496      PMCID: PMC2917763          DOI: 10.1016/0140-6736(93)90064-n

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  STUDIES ON CYSTICERCOSIS IN CENTRAL AMERICA AND PANAMA.

Authors:  P N ACHA; F J AGUILAR
Journal:  Am J Trop Med Hyg       Date:  1964-01       Impact factor: 2.345

2.  Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG).

Authors:  J F Diaz; M Verastegui; R H Gilman; V C Tsang; J B Pilcher; C Gallo; H H Garcia; P Torres; T Montenegro; E Miranda
Journal:  Am J Trop Med Hyg       Date:  1992-05       Impact factor: 2.345

3.  An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium).

Authors:  V C Tsang; J A Brand; A E Boyer
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

4.  Introduction of Taenia solium into west New Guinea with a note on an epidemic of burns from cysticercus epilepsy in the Ekari people of the Wissel Lakes area.

Authors:  D C Gajdusek
Journal:  P N G Med J       Date:  1978-12

5.  Detection of Cysticercus cellulosae antigens in cerebrospinal fluid by dot enzyme-linked immunosorbent assay (Dot-ELISA) and standard ELISA.

Authors:  E Téllez-Girón; M C Ramos; L Dufour; P Alvarez; M Montante
Journal:  Am J Trop Med Hyg       Date:  1987-07       Impact factor: 2.345

6.  Epidemic of burns in New Guinea due to cerebral cysticercosis.

Authors:  J J Bending; J C Catford
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

Review 7.  Neurocysticercosis: an update.

Authors:  O H Del Brutto; J Sotelo
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

Review 8.  Recent advances in the diagnosis and treatment of cerebral cysticercosis.

Authors:  T E Nash; F A Neva
Journal:  N Engl J Med       Date:  1984-12-06       Impact factor: 91.245

9.  Cysticercosis cerebri. Review of 127 cases.

Authors:  G F McCormick; C S Zee; J Heiden
Journal:  Arch Neurol       Date:  1982-09

10.  Enzyme-linked immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium.

Authors:  A R Diwan; M Coker-Vann; P Brown; D B Subianto; R Yolken; R Desowitz; A Escobar; C J Gibbs; D C Gajdusek
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

View more
  36 in total

1.  Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru.

Authors:  H H Garcia; R H Gilman; M Catacora; M Verastegui; A E Gonzalez; V C Tsang
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

2.  Neurocysticercosis in a patient in Canada.

Authors:  Jorge G Burneo; Ian Plener; Hector H Garcia
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

3.  Systemic cysticercosis.

Authors:  Aftab Ahmad; Leonard L L Yeo; Vijay K Sharma
Journal:  Intern Emerg Med       Date:  2011-03-05       Impact factor: 3.397

Review 4.  Epidemiology of the epilepsies.

Authors:  J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 5.  Controversies in the management of cysticercosis.

Authors:  C Evans; H H Garcia; R H Gilman; J S Friedland
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

Review 6.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

7.  Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa.

Authors:  Humberto Foyaca-Sibat; Linda D Cowan; Hélène Carabin; Irene Targonska; Mushtaq A Anwary; Gilberto Serrano-Ocaña; Rosina C Krecek; A Lee Willingham
Journal:  PLoS Negl Trop Dis       Date:  2009-12-08

8.  Seroprevalence of cysticercosis in children and young adults living in a helminth endemic community in leyte, the Philippines.

Authors:  Jin-Mei Xu; Luz P Acosta; Min Hou; Daria L Manalo; Mario Jiz; Blanca Jarilla; Archie O Pablo; Remigio M Ovleda; Gretchen Langdon; Stephen T McGarvey; Jonathan D Kurtis; Jennifer F Friedman; Hai-Wei Wu
Journal:  J Trop Med       Date:  2010-03-29

Review 9.  Immunology of Taenia solium taeniasis and human cysticercosis.

Authors:  H H Garcia; S Rodriguez; J S Friedland
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

10.  Workshop report: Developing an international collaborative research network in neurocysticercosis and epilepsy.

Authors:  Jorge G Burneo; Oscar Del Brutto; Antonio V Delgado-Escueta; Armando E Gonzalez; Marco T Medina; Silvia M Montano; Luz M Moyano; Theodore Nash; Gustavo Roman; Gagandeep Singh; A Clinton White; Samuel Wiebe; Hector H Garcia
Journal:  Epilepsia       Date:  2009-05       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.